ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Clover Biopharmaceuticals Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 653.92% and Operating profit at 30.73% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
- CASH AND EQV(HY) Lowest at HKD 444.17 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 1178.03%, its profits have fallen by -849.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Clover Biopharmaceuticals Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Clover Biopharmaceuticals Ltd.
-100.0%
5.59
111.15%
Hang Seng Hong Kong
8.99%
0.36
24.71%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
653.92%
EBIT Growth (5y)
30.73%
EBIT to Interest (avg)
-151.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
-0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.64
EV to EBIT
-0.58
EV to EBITDA
-0.61
EV to Capital Employed
-0.27
EV to Sales
14.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at HKD -108.97 MM
RAW MATERIAL COST(Y)
Fallen by -96.54% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 1.38 times
OPERATING PROFIT(Q)
Highest at HKD -106.51 MM
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 444.17 MM
Here's what is working for Clover Biopharmaceuticals Ltd.
Net Profit
Higher at HKD -108.97 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Operating Profit
Highest at HKD -106.51 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Debtors Turnover Ratio
Highest at 1.38 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -96.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Clover Biopharmaceuticals Ltd.
Cash and Eqv
Lowest at HKD 444.17 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
